Marfan Syndrome Clinical Trials 2024

Marfan Syndrome Clinical Trials 2024

Marfan Syndrome research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in marfan syndrome clinical trials today.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to marfan syndrome

What are the top hospitals conducting marfan syndrome research?

In the realm of clinical trials for Marfan syndrome, several hospitals are making significant strides in understanding and treating this rare genetic disorder. Texas Children's Hospital in Houston is at the forefront, currently conducting one active trial specific to Marfan syndrome. Over the years, they have contributed to three such trials since recording their first study in 2007. In Worcester, UMass Memorial Health Care - University Campus is also dedicated to advancing knowledge about Marfan syndrome with one ongoing trial and a single previous trial conducted since their inaugural investigation in 2014.

Meanwhile, on the West Coast, The Vision Center located in Los Angeles has recently embarked on an important journey by initiating its first-ever clinical trial for Marfan syndrome. Similarly, Indiana University's Riley Hospital for Children in Indianapolis recognizes the importance of research and presently has an active trial underway as well.

Notably, Harvard University's Boston Children's Hospital is playing a crucial role within this field as they too conduct an ongoing clinical trial focusing solely on Marfan syndrome cases. Although these institutions may have fewer recorded studies compared to other conditions or locations mentioned earlier; nevertheless they showcase their commitment towards bettering treatments options available to patients dealing with this rare genetic disorder worldwide.

These hospitals serve as beacons of hope for individuals living with Marfan syndrome by pushing boundaries through scientific exploration and innovation. Through their dedication and collaborative efforts across various regions within America’s medical landscape comes forth immense potential breakthroughs that will ultimately enhance quality of life for those affected by this complex condition

Which are the best cities for marfan syndrome clinical trials?

When it comes to Marfan syndrome clinical trials, several cities show promise in advancing research and treatment options. Houston, Texas takes the lead with 2 active trials exploring innovative approaches like the Control Group and Artisan Aphakia Intraocular Lens. Worcester, Massachusetts follows closely behind with 1 ongoing trial investigating the Custom Made Fenestrated or Branched Stent Graft. Additionally, Los Angeles, California; Indianapolis, Indiana; and Boston, Massachusetts each have 1 active trial focusing on treatments such as the Artisan Aphakia Intraocular Lens. These cities offer individuals with Marfan syndrome opportunities to participate in cutting-edge clinical trials that could potentially enhance their quality of life and provide valuable insights for future advancements in care.

Which are the top treatments for marfan syndrome being explored in clinical trials?

Clinical trials are actively exploring top treatments for Marfan syndrome, a genetic disorder affecting connective tissue. Among the leading contenders are:

  • Control Group: Currently involved in one active trial and with one all-time Marfan syndrome trial recorded since its listing in 2023.
  • Custom Made Fenestrated or Branched Stent Graft: Showing promise, this treatment is being tested in one active trial and has appeared in one all-time Marfan syndrome trial since it was first listed back in 2014. These innovative approaches hold potential for improving outcomes for individuals with Marfan syndrome and highlighting new avenues of research to address this complex condition.
What are the most recent clinical trials for marfan syndrome?

In recent clinical trials for Marfan syndrome, an innovative treatment option called the Artisan Aphakia Intraocular Lens has shown potential in improving outcomes for individuals with this genetic disorder. This Phase 3 trial, which became available on 1/1/2012, aims to address specific ocular complications associated with Marfan syndrome. By focusing on advancements within this field of research, scientists and medical professionals are working towards providing better care and enhanced quality of life for those affected by Marfan syndrome.

What marfan syndrome clinical trials were recently completed?

Several clinical trials investigating potential treatments for Marfan syndrome have recently concluded, bringing hope to individuals affected by this genetic disorder. In October 2021, a trial sponsored by the National Institutes of Health (NIH) focused on evaluating the effectiveness of Losartan came to an end. Another significant trial completed in September 2021 was conducted by Baylor College of Medicine and aimed at studying the impact of Valsartan on Marfan-related cardiovascular complications. These recent advancements highlight ongoing efforts to find novel therapies and improve outcomes for patients with Marfan syndrome.